Home > List All Publishers > Current Partnering

Current Partnering

CurrentPartnering is an online provider of best practice, business information and intelligence for dealmakers. CurrentPartnering publish a series of reports, providing access to critical decision making and best practice intelligence from leaders in business development and licensing.

Best practice – reports providing insight into best practice and trends in partnering
Directories – detailed analysis of partnering interests and activity of companies worldwide
Contracts – obtain an insight and understanding of the terms acceptable to a potential partner

CurrentPartnering was established in 2007 by Wildwood Ventures Ltd to offer an objective and informal business tool for business development executives, providing an opportunity for the dissemination of the latest trends in partnering activity within the biopharma sector.

List of reports from Current Partnering

Cancer Monoclonal Antibody Partnering Agreements - CP22012 - May2013v3 5/1/2013 \| published by: Current Partnering ... deals Disclosed headlines, upfronts, milestones and royalties by stage of development Cancer monoclonal antibody partnering contract documents Top cancer monoclonal antibody deals by value The Cancer Monoclonal Antibody Partnering Agreements report provides an understanding and ... \| read more...	$1,995.00
Antibiotics Partnering Agreements - CP2119 - May2013v1 5/1/2013 \| published by: Current Partnering ... royalties by stage of development Antibiotics partnering contract documents Top antibiotics deals by value The Antibiotics Partnering Terms and Agreements report provides an understanding and access to the antibiotics partnering deals and agreements entered into ... \| read more...	$1,795.00
Discovery to Clinical Stage Partnering Terms and Agreements in Pharma Biotech Diagnostics - CP2059 - May2013v3 5/1/2013 \| published by: Current Partnering ... the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter discovery, preclinical and clinical stage partnering deals. The majority of deals are where the licensee obtains ... \| read more...	$4,995.00
Pre-clinical Stage Partnering Terms and Agreements in Pharma Biotech Diagnostics - CP2058 - May2013v3 5/1/2013 \| published by: Current Partnering ... report provides a detailed understanding and analysis of how and why companies enter preclinical stage partnering deals. The majority of deals are where the licensee obtains a right or an option right to license the ... \| read more...	$2,995.00
Cancer Vaccine Partnering Agreements - CP22011- Apr2013v3 5/1/2013 \| published by: Current Partnering ... upfronts, milestones and royalties by stage of development Cancer vaccine partnering contract documents Top cancer vaccine deals by value The Cancer Vaccine Partnering Agreements report provides an understanding and access to the cancer vaccine partnering ... \| read more...	$1,795.00
Antibody Partnering Agreements - CP2113 - May2013v3 5/1/2013 \| published by: Current Partnering ... analysis of how and why companies enter antibody partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors antibody technology. ... \| read more...	$2,995.00
Discovery Stage Partnering Terms and Agreements in Pharma Biotech Diagnostics - CP2056 - May2013v3 5/1/2013 \| published by: Current Partnering ... report provides a detailed understanding and analysis of how and why companies enter discovery stage partnering deals. The majority of deals are where the licensee obtains a right or an option right to license the ... \| read more...	$2,995.00
Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 4/1/2013 \| published by: Current Partnering ... report provides a detailed understanding and analysis of how and why companies enter clinical stage partnering deals. The majority of deals are where the licensee obtains a right or an option right to license the ... \| read more...	$2,995.00
Pharmacogenomics Partnering Terms and Agreements 4/1/2013 \| published by: Current Partnering ... analysis of how and why companies enter pharmacogenomic partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors pharmacogenomic technology. ... \| read more...	$2,795.00
Personalized Medicine Partnering Agreements - CP2108 - Apr2013v5 4/1/2013 \| published by: Current Partnering ... to the personalized medicine partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter personalized medicine partnering deals. The ... \| read more...	$4,995.00
Companion Diagnostics Partnering Terms & Agreements 4/1/2013 \| published by: Current Partnering ... understanding and analysis of how and why companies enter companion diagnostic partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the ... \| read more...	$2,795.00
Biomarker Partnering Terms and Agreements 3/1/2013 \| published by: Current Partnering ... agreement structure Biomarker partnering contract documents Top biomarker deals by value Most active biomarker dealmakers The Biomarker Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements ... \| read more...	$2,795.00
Bioinformatics Partnering Terms and Agreements 3/1/2013 \| published by: Current Partnering ... analysis Partnering agreement structure Partnering contract documents Top deals by value Most active dealmakers Average deal terms for bioinformatics The Bioinformatics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the bioinformatics ... \| read more...	$3,795.00
Orphan Drugs Partnering Terms and Agreements 2/1/2013 \| published by: Current Partnering ... upfronts, milestones and royalties by stage of development Orphan drugs partnering contract documents Top orphan drugs deals by value The OrphanDrugs Partnering Terms and Agreements report provides an understanding and access to the orphan drugs ... \| read more...	$1,795.00
Regenerative medicine and Stem cells Partnering Terms and Agreements 2/1/2013 \| published by: Current Partnering ... companies. Trends in regenerative medicine and stem cells deals Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by value Most active dealmakers Average deal terms for regenerative medicine and stem cells The ... \| read more...	$2,695.00
Partnering Deals and Alliances with Big Pharma 2/1/2013 \| published by: Current Partnering ... Big Pharma provides the user with the following key benefits: Detailed partnering activity profiles for each of the top 50 big pharma companies Over 300 charts showing a company’s dealmaking activity since 2005, allowing quick ... \| read more...	$2,995.00
Dry Eye Partnering 2007-2013 1/1/2013 \| published by: Current Partnering ... by value Deals listed by company A-Z, industry sector, stage of development, technology type Dry Eye Partnering 2007-2013 provides understanding and access to the dry eye partnering deals and agreements entered into by the worlds ... \| read more...	$995.00
Manufacturing and Supply Partnering Terms and Agreements 1/1/2013 \| published by: Current Partnering ... analysis of how and why companies enter manufacturing and supply deals. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect ... \| read more...	$2,995.00
Vaccine Partnering Terms and Agreements 1/1/2013 \| published by: Current Partnering ... Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by value Most active dealmakers Average deal terms for vaccines The report provides a detailed understanding and analysis of how and why companies enter ... \| read more...	$2,695.00
Angioedema Partnering 2007-2013 1/1/2013 \| published by: Current Partnering ... by company A-Z, industry sector, stage of development, technology type Angioedema Partnering 2007-2013 provides understanding and access to the angioedema partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides ... \| read more...	$995.00
Burns Partnering 2007-2013 1/1/2013 \| published by: Current Partnering ... by company A-Z, industry sector, stage of development, technology type Burns Partnering 2007-2013 provides understanding and access to the burns partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides ... \| read more...	$995.00
Cosmetics Partnering 2007-2013 1/1/2013 \| published by: Current Partnering ... by company A-Z, industry sector, stage of development, technology type Cosmetics Partnering 2007-2013 provides understanding and access to the cosmetics partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides ... \| read more...	$995.00
Dermatitis Partnering 2007-2013 1/1/2013 \| published by: Current Partnering ... by company A-Z, industry sector, stage of development, technology type Dermatitis Partnering 2007-2013 provides understanding and access to the dermatitis partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides ... \| read more...	$995.00
Retinopathy Partnering 2007-2013 1/1/2013 \| published by: Current Partnering ... by company A-Z, industry sector, stage of development, technology type Retinopathy Partnering 2007-2013 provides understanding and access to the retinopathy partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides ... \| read more...	$995.00
Public Health Partnering Terms and Agreements 1/1/2013 \| published by: Current Partnering ... the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This report provides details of the latest ... \| read more...	$2,695.00

< prev 1 2 3 4 5 6 7 8 next >